NOVA Stock Price and Chart — SWB:NOVA

Overview

Financials News Ideas Discussions Forecast Seasonals Bonds

Key facts today

Novo Nordisk's shares rose 2.87% after a study revealed Wegovy's heart benefits, showing a 57% lower risk of heart attack or stroke compared to Eli Lilly's treatments.

Analyze the impact Analyze the impact

About Novo Nordisk A/S Class B

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Check out other big names from the same industry as NOVA.